30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Ken Lee

Track

Insider profile

Currently holds positions in BioCryst Pharmaceuticals Inc, Hyperion DeFi Inc, POZEN Inc and Old API Wind-Down Ltd

Performance

Overall performance
1.6
Performance over holding periods
1.6
30 days 90 days 120 days
Average return -15% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director BioCryst Pharmaceuticals Inc June 27, 2011 -
Independent Director Hyperion DeFi Inc March 26, 2018 -
Lead Independent Director POZEN Inc Jan. 1, 2005 -
Lead Independent Director Old API Wind-Down Ltd Feb. 5, 2016 -
Independent Director Maxygen Inc Sept. 17, 2009 - Aug. 29, 2013
Ken Lee's trades of Hyperion DeFi Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-23 2022-05-19
B Purchase
55,767 +16.4%
371.94
US$370,421 		55,767 +16.4% 371.94 US$370,421
2021-06-15 2021-06-15
B Purchase
15,840 -45.3%
122.26
US$3,085,075 		15,840 -45.3% 122.26 US$3,085,075
2021-06-15 2021-06-14
B Purchase
40,190 -27.5%
278.29
US$495,974 		40,190 -27.5% 278.29 US$495,974
2021-06-15 2021-06-11
B Purchase
2,000 +10.3%
5.38
US$10,760 		2,000 +10.3% 5.38 US$10,760